Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Prif Awdur: | Paul, Pulock |
---|---|
Awduron Eraill: | Azam,Faruque |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2024
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/23954 |
Eitemau Tebyg
-
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
gan: Rahman, Tasnim
Cyhoeddwyd: (2024) -
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
gan: Hoque, Ismoth Ara
Cyhoeddwyd: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Karim, Samia Binte
Cyhoeddwyd: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Flora, Sanzida Alam
Cyhoeddwyd: (2024) -
A review on targeted therapies for lung cancer
gan: Ashraf, Anushey
Cyhoeddwyd: (2023)